Vivan renews five-year lease at UK biotech hub White City Place
The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma Vivan Therapeutics has signed a...
adminph
Drug discovery within the patient
The idea of using microorganisms as a source of new active ingredients is not new. Numerous drugs have already been...
HBC Immunology shares promising results for prostate cancer co-therapy
There are around 55,100 new prostate cancer cases in the UK every year HBC Immunology (HBCI) has announced that an...
Richard Hopkins
NK:IO has appointed Richard Hopkins as Chief Executive Officer NK:IO has appointed Richard Hopkins, an experienced biologics developer, as its...
Specific type of DNA could be a target of future cancer therapies
Research published in Nature Genetics on Oct.14, by Yale Cancer Center researchers at Yale School of Medicine, found a higher...
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Study reveals potential new strategy for managing inflammatory bowel disease Celltrion has announced groundbreaking results from a two-year study on...
Alleo and Ubiquigent unite to accelerate drug discovery
Partnership to harness AI for DUB-focused preclinical programmes Dundee-based Ubiquigent Limited and San Francisco’s Alleo Labs Corp have entered a...
Bayer submits EU marketing authorization application for elinzanetant to treat moderate to severe vasomotor symptoms
Bayer has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for elinzanetant for the treatment of...
Lundbeck to acquire Longboard Pharmaceuticals in strategic deal
Acquisition to enhance Lundbeck’s neuroscience pipeline Lundbeck has announced a significant step forward in its Focused Innovator strategy with the...
Transgene’s cancer vaccine trial shows mixed results
Phase 2 study of TG4001 shows promise in cervical cancer patients Transgene, a biotech company specializing in virus-based immunotherapies for...
Gene therapy automatically converts omega-6 to omega-3 fatty acids in the body
According to the Centers for Disease Control, nearly 20% of children and teens are considered obese. Research shows it can...
FDA approves new treatment for hemophilia A or B
Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of...
Heart patient goes home hours after live-streamed valve replacement
Sheffield cardiologists demonstrate cutting-edge TAVI procedure Cardiologists at Sheffield Teaching Hospitals NHS Foundation Trust have performed a cutting-edge heart valve...
Johnson & Johnson myeloma drug recommended for NHS use
Teclistamab offers hope for patients exhausting treatment options Teclistamab (Tecvayli), a drug manufactured by Johnson & Johnson, has received a...
Purespring Therapeutics secures £80 million in Series B funding
New investment to advance gene therapies for kidney diseases Purespring Therapeutics has raised £80m in an oversubscribed Series B financing...
Sanofi launches high-dose flu vaccine in the UK
New vaccine aims to protect older adults from severe flu complications Sanofi has announced the launch of its high-dose egg-based...
Key molecule in wound healing identified
A new study from Karolinska Institutet in Sweden and the Chinese Academy of Medical Sciences has identified an RNA molecule...
Kyowa Kirin announces positive interim data for lymphoma treatment
Real-world studies show effectiveness of mogamulizumab in routine practice Kyowa Kirin International (KKI) has announced positive interim findings from three...
Astellas and AviadoBio announce exclusive gene therapy deal
AviadoBio to receive up to £1.8 billion in potential payments AviadoBio and Astellas Pharma have entered into an exclusive option...
Novo Nordisk launches new initiative to prevent childhood obesity in disadvantaged urban communities
Novo Nordisk today announced a new global initiative to prevent obesity in children. The Childhood Obesity Prevention Initiative aims to...
